Literature DB >> 4064333

Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids.

M Duran, D Ketting, R van Vossen, T E Beckeringh, L Dorland, L Bruinvis, S K Wadman.   

Abstract

Octanoyl-beta-D-glucuronide was identified in the urine of five patients with hypoketotic hypoglycemia and dicarboxylic aciduria due to a defective beta-oxidation of medium-chain fatty acids. Two subjects who ingested large amounts of medium-chain triglycerides also excreted large amounts of the glucuronide. The substance was extracted from the urine with ethyl acetate and analyzed by: (1) gas chromatography/mass spectrometry (GC-MS) of the trimethylsilyl derivative and (2) preparative one-dimensional thin-layer chromatography followed by enzymatic hydrolysis with beta-glucuronidase and again GC-MS. A quantitative analysis was performed indirectly by measuring the urinary bound octanoate after the removal of octanoylcarnitine. Octanoylglucuronide represents an additional mechanism for the detoxification of octanoate; its formation may be of help for the maintenance of carnitine homeostasis in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064333     DOI: 10.1016/0009-8981(85)90100-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  Tyrosinaemia type I with normal levels of plasma tyrosine.

Authors:  I T de Almeida; P P Leandro; M F Silva; C Silveira; A da Silva; J S de Sousa; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Mild form of methylmalonic aciduria misdiagnosed as propionic acidaemia during a ketotic crisis.

Authors:  I T de Almeida; M Duran; M F Silva; R Portela; A Cabral; T Tasso; F Eusébio; C Silveira
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  A patient with mevalonic aciduria presenting with hepatosplenomegaly, congenital anaemia, thrombocytopenia and leukocytosis.

Authors:  J B de Klerk; M Duran; L Dorland; H A Brouwers; L Bruinvis; D Ketting
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 4.  The inborn errors of mitochondrial fatty acid oxidation.

Authors:  C Vianey-Liaud; P Divry; N Gregersen; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Maternal PKU syndrome in an exceptional family with unexpected PKU.

Authors:  J B De Klerk; S K Wadman; H J Dijkhuis; E E Meuleman
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

6.  Identification of new medium-chain acylcarnitines present in urine of a patient with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  R Libert; F Van Hoof; M Thillaye; M F Vincent; M C Nassogne; V Stroobant; E de Hoffmann; A Schanck
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

7.  Urinary D-4-hydroxyphenyllactate, D-phenyllactate and D-2-hydroxyisocaproate, abnormalities of bacterial origin.

Authors:  L J Spaapen; D Ketting; S K Wadman; L Bruinvis; M Duran
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

8.  Urinary metabotypes of newborns with perinatal asphyxia undergoing therapeutic hypothermia.

Authors:  Enrico Valerio; Veronica Mardegan; Matteo Stocchero; Maria Elena Cavicchiolo; Paola Pirillo; Gabriele Poloniato; Gianluca D'Onofrio; Luca Bonadies; Giuseppe Giordano; Eugenio Baraldi
Journal:  PLoS One       Date:  2022-08-16       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.